Upadacitinib for the treatment of alopecia areata and severe atopic dermatitis in a paediatric patient: A case report

This case report describes the first successful treatment of alopecia areata and atopic dermatitis with the Janus kinase 1 inhibitor upadacitinib in a paediatric patient. After minimal response to topical corticosteroids and spironolactone, improvements in hair growth on the scalp and body were note...

Descripción completa

Detalles Bibliográficos
Autores principales: Bourkas, Adrienn N, Sibbald, Cathryn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
JCMS Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9709177/
https://www.ncbi.nlm.nih.gov/pubmed/36467009
http://dx.doi.org/10.1177/2050313X221138452
_version_ 1784841089772945408
author Bourkas, Adrienn N
Sibbald, Cathryn
author_facet Bourkas, Adrienn N
Sibbald, Cathryn
author_sort Bourkas, Adrienn N
collection PubMed
description This case report describes the first successful treatment of alopecia areata and atopic dermatitis with the Janus kinase 1 inhibitor upadacitinib in a paediatric patient. After minimal response to topical corticosteroids and spironolactone, improvements in hair growth on the scalp and body were noted after only 6 weeks of upadacitinib treatment.
format Online
Article
Text
id pubmed-9709177
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-97091772022-12-01 Upadacitinib for the treatment of alopecia areata and severe atopic dermatitis in a paediatric patient: A case report Bourkas, Adrienn N Sibbald, Cathryn SAGE Open Med Case Rep JCMS Case Report This case report describes the first successful treatment of alopecia areata and atopic dermatitis with the Janus kinase 1 inhibitor upadacitinib in a paediatric patient. After minimal response to topical corticosteroids and spironolactone, improvements in hair growth on the scalp and body were noted after only 6 weeks of upadacitinib treatment. SAGE Publications 2022-11-28 /pmc/articles/PMC9709177/ /pubmed/36467009 http://dx.doi.org/10.1177/2050313X221138452 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle JCMS Case Report
Bourkas, Adrienn N
Sibbald, Cathryn
Upadacitinib for the treatment of alopecia areata and severe atopic dermatitis in a paediatric patient: A case report
title Upadacitinib for the treatment of alopecia areata and severe atopic dermatitis in a paediatric patient: A case report
title_full Upadacitinib for the treatment of alopecia areata and severe atopic dermatitis in a paediatric patient: A case report
title_fullStr Upadacitinib for the treatment of alopecia areata and severe atopic dermatitis in a paediatric patient: A case report
title_full_unstemmed Upadacitinib for the treatment of alopecia areata and severe atopic dermatitis in a paediatric patient: A case report
title_short Upadacitinib for the treatment of alopecia areata and severe atopic dermatitis in a paediatric patient: A case report
title_sort upadacitinib for the treatment of alopecia areata and severe atopic dermatitis in a paediatric patient: a case report
topic JCMS Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9709177/
https://www.ncbi.nlm.nih.gov/pubmed/36467009
http://dx.doi.org/10.1177/2050313X221138452
work_keys_str_mv AT bourkasadriennn upadacitinibforthetreatmentofalopeciaareataandsevereatopicdermatitisinapaediatricpatientacasereport
AT sibbaldcathryn upadacitinibforthetreatmentofalopeciaareataandsevereatopicdermatitisinapaediatricpatientacasereport

Ejemplares similares